EPKINLY 48mg/0.8ml (Epcoritamab Injection) 48mg/0.8ml

EPKINLY 48mg/0.8ml injection is a prescription therapy for certain blood cancers. This 48mg/0.8ml single-dose vial is stored at 2-8°C and used under medical supervision. Discover how epcoritamab supports targeted treatment pathways in oncology care.

Strength

48mg/0.8ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Genmab US, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Epcoritamab, the active ingredient in EPKINLY 48mg/0.8ml, is used to treat specific types of non-Hodgkin lymphoma. Patients and caregivers often ask what is epcoritamab used for, as it targets CD3 and CD20 proteins to help manage relapsed or refractory disease. This therapy is designed for adults who have tried other treatments without success.

Side Effects

EPKINLY 48mg/0.8ml works by helping the immune system recognize and attack cancer cells. Common effects include temporary changes in blood cell counts, which may require monitoring. Some users report fatigue or mild reactions at the injection site during treatment.

Precautions & Warnings

EPKINLY 48mg/0.8ml is administered by healthcare professionals in a clinical setting. Keep the vial refrigerated between 2-8°C and protect it from light. Patients should report any signs of infection, fever, or unusual symptoms immediately to their care team.

Avoid Interactions

Limited data exists on drug interactions with epcoritamab, but caution is advised with immunosuppressants or live vaccines. Avoid alcohol and other medications that may affect the immune system without consulting a doctor. Always inform your healthcare provider about all current medications.

Frequently Asked Questions

Epcoritamab is used to treat certain types of non-Hodgkin lymphoma in adults who have not responded to other therapies.

Store the vial refrigerated between 2-8°C and protect it from light until ready for use.

EPKINLY 48mg/0.8ml is a targeted therapy, not a traditional chemotherapy, though it works to treat cancer.

Consult your doctor before taking any new medications, including over-the-counter drugs or supplements.

Dosage and frequency are determined by a healthcare provider based on individual treatment plans.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.